ESG Report 2020

Major R&D Pipeline Indications： Diabetes Osteoporosis Eczema &Asthma Rheumatoid Arthritis Xerophthalmia Conjunctivitis Atopic Dermatitis Inflammatory Bowel Disease Dermatosis Product Stage of Research and Development Polyvinyl Alcohol Eye Drops Sodium Hyaluronate Eye Drops Moxifloxacin Eye Drops WXSH0150 Insulin Aspart Injection Insulin Aspart 30 Injection Liraglutide Injection Insulin Degludec Injection Insulin Aspart 50 Injection Insulin Degludec/ Liraglutide Injection Semaglutide Injection GLP-1 Oral Preparation Insulin Degludec/ Insulin Aspart Osteoporosis monoclonal antibody Anti-osteoporosis Petides Dupilumab monoclonal antibody LB1091 LB2002 LB2101 Mupirocin Ointment 52 Environmental, Social and Governance Report 2020 The United Laboratories International Holdings Limited R&D Stages： Production declaration Clinical trial Clinical declaration Preclinical